Milford, NJ, United States of America

Francis Parker Huger

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Marion Roussel. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francis Parker Huger. Retrieved from https://idiyas.com/inventor/francis-parker-huger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Francis Parker Huger

Introduction

Francis Parker Huger is a notable inventor based in Milford, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of convulsions. His innovative approach has led to the development of a unique method that offers relief to patients in need.

Latest Patents

Huger holds a patent for the use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines. This invention relates to a method of treating a patient in need of relief from convulsions. The method comprises administering a convulsion-alleviating amount of a compound defined by a specific formula. This patent showcases his commitment to advancing medical treatments and improving patient care. He has 1 patent to his name.

Career Highlights

Francis Parker Huger has worked with Hoechst Marion Roussel, a company known for its contributions to pharmaceuticals. His role there has allowed him to collaborate with other talented professionals in the field. His work has been instrumental in developing new therapeutic methods.

Collaborations

Some of his notable coworkers include Craig P. Smith and Sathapana Kongsamut. Their collaboration has likely contributed to the innovative environment at Hoechst Marion Roussel.

Conclusion

Francis Parker Huger is a distinguished inventor whose work in treating convulsions has made a significant impact in the medical field. His dedication to innovation continues to inspire advancements in patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…